Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2009 1
2012 1
2018 1
2021 1
2022 1
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

5 results

Results by year

Filters applied: . Clear all
Page 1
Diagnostic significance of stromal changes in biopsies of prostate adenocarcinoma.
Dzaparidze G, Kazachonok D, Gvozdkov A, Taelma H, Laht K, Minajeva A. Dzaparidze G, et al. Pathol Res Pract. 2021 Jun;222:153436. doi: 10.1016/j.prp.2021.153436. Epub 2021 Apr 8. Pathol Res Pract. 2021. PMID: 33857855
The research aims to evaluate the potential of stromal changes as a supplementary tool to predict the presence of higher grade carcinomas in the prostate using Masson's trichrome and Fanconi anemia complementation group M (FANCM) antibody staini …
The research aims to evaluate the potential of stromal changes as a supplementary tool to predict the presence of higher grade carcinomas in …
Bi-allelic Recessive Loss-of-Function Variants in FANCM Cause Non-obstructive Azoospermia.
Kasak L, Punab M, Nagirnaja L, Grigorova M, Minajeva A, Lopes AM, Punab AM, Aston KI, Carvalho F, Laasik E, Smith LB; GEMINI Consortium; Conrad DF, Laan M. Kasak L, et al. Am J Hum Genet. 2018 Aug 2;103(2):200-212. doi: 10.1016/j.ajhg.2018.07.005. Am J Hum Genet. 2018. PMID: 30075111 Free PMC article.
Compound heterozygous loss-of-function (LoF) variants in FANCM (Fanconi anemia complementation group M) were detected as the most likely cause for their condition. ...
Compound heterozygous loss-of-function (LoF) variants in FANCM (Fanconi anemia complementation group M) w …
Impaired FANCD2 monoubiquitination and hypersensitivity to camptothecin uniquely characterize Fanconi anemia complementation group M.
Singh TR, Bakker ST, Agarwal S, Jansen M, Grassman E, Godthelp BC, Ali AM, Du CH, Rooimans MA, Fan Q, Wahengbam K, Steltenpool J, Andreassen PR, Williams DA, Joenje H, de Winter JP, Meetei AR. Singh TR, et al. Blood. 2009 Jul 2;114(1):174-80. doi: 10.1182/blood-2009-02-207811. Epub 2009 May 7. Blood. 2009. PMID: 19423727 Free PMC article.
The Fanconi anemia ortholog FANCM ensures ordered homologous recombination in both somatic and meiotic cells in Arabidopsis.
Knoll A, Higgins JD, Seeliger K, Reha SJ, Dangel NJ, Bauknecht M, Schröpfer S, Franklin FC, Puchta H. Knoll A, et al. Plant Cell. 2012 Apr;24(4):1448-64. doi: 10.1105/tpc.112.096644. Epub 2012 Apr 30. Plant Cell. 2012. PMID: 22547783 Free PMC article.
It is caused by single mutations in the FANC genes, one of which encodes the DNA translocase FANCM (for Fanconi anemia complementation group M), which is required for the repair of DNA interstrand cross-links to ensure replication progression. . …
It is caused by single mutations in the FANC genes, one of which encodes the DNA translocase FANCM (for Fanconi anemia comp …
Prevalence of FANCM germline variants in BRCA1/2 negative breast and/or ovarian cancer patients from Pakistan.
Rashid MU, Muhammad N, Shehzad U, Khan FA, Loya A, Hamann U. Rashid MU, et al. Fam Cancer. 2023 Jan;22(1):31-41. doi: 10.1007/s10689-022-00304-1. Epub 2022 Jul 8. Fam Cancer. 2023. PMID: 35802266
The Fanconi anemia complementation group M (FANCM) gene is a potential candidate for breast/ovarian cancer susceptibility in European populations. ...
The Fanconi anemia complementation group M (FANCM) gene is a potential candidate for breast/ovarian cance …